Pfizer Inc. sell Snowman
Start price
07.12.23
/
50%
€26.80
Target price
07.12.24
-
Performance (%)
2.23%
Price
22:26
€26.24
Summary
This prediction is currently active. The SELL prediction by Snowman shows the price for Pfizer Inc. has slightly increased by 2.23%. A total of €1.16 was paid as dividends for this prediction. This prediction currently runs until 07.12.24. The prediction end date can be changed by Snowman at any time. Snowman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pfizer Inc. | 0.039% | 0.039% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
According to Snowman what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
Small Risks for its business
Differentiated customer and product portfolio
Known brand
Market Leader or Top 3
Cons
Comments by Snowman for this prediction
In the thread Pfizer Inc. diskutieren
Sell Pfizer Inc.
Stopped prediction by Snowman for Pfizer Inc.
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.74
20.07.22
20.07.22
€55.00
20.07.23
20.07.23
-33.55%
21.07.23
21.07.23
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.01
18.12.20
18.12.20
€34.00
18.12.21
18.12.21
-5.35%
15.03.21
15.03.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques